Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SENS compared with RNA: revenue, margins and what each company keeps, and the suppliers and customers both name
SENS
Senseonics Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
RNA
Atrium Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SENS
Senseonics Holdings, Inc.
vs
RNA
Atrium Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
SENS: latest quarter is a loss; flow not drawable. RNA: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SENS
3
—
BSI
unlisted
supplier
—
NPG
unlisted
supplier
—
Ascensia Diabetes Care Holdings AG ("Ascensia")
unlisted
customer
Shared
0
No disclosed counterparties: RNA.
Only RNA
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
SENS
Senseonics Holdings, Inc.
Change
8.94
▼
−6.00%
Mkt cap
$502.8M
Revenue
$14M
Q2 FY26
Revenue
$35M
FY25
RNA
Atrium Therapeutics, Inc.
Change
8.57
▲
+3.59%
Regular session
Nov 2 '26
Mkt cap
$141.5M
Revenue
$3M
Q2 FY26
Revenue
—
vs
Compare
Regular session
Nov 2 '26
SENS
Senseonics Holdings, Inc.
vs
RNA
Atrium Therapeutics, Inc.
8.94
▼
−6.00%
Price
8.57
▲
+3.59%
$502.8M
Mkt cap
$141.5M
Q2 FY26
$14M
Revenue
$3M
Q2 FY26
FY25
$35M
Revenue
—
Change
Change
SENS
8.94
▼
−6.00%
vs
RNA
8.57
▲
+3.59%
Regular session
Nov 2 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SENS, solid
RNA, dashed